MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression Biotech Investing
Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT Biotech Investing
Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal Pharmaceutical Investing
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease Biotech Investing
Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas Biotech Investing
Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome Pharmaceutical Investing
AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide Generator and Delivery System Pharmaceutical Investing
